Pharma R&D Today

Ideas and Insight supporting all stages of Drug Discovery & Development

Select category
Search this blog

Best Practices for Post-Market Surveillance Processes

Posted on November 13th, 2015 by in Pharmacovigilance

Medical-safety-2

Donna Sees, an Information Consultant with PharmIntell Consulting, has been a librarian in the medical field for more than 10 years. In this article, she discusses post-market surveillance processes and best practices for medical device companies.

Learn how PharmIntell Consulting took advantage of QUOSA.

R&D Solutions for Pharma & Life Sciences

We're happy to discuss your needs and show you how Elsevier's Solution can help.

Contact Sales
Neal Katz


Director of Solutions Marketing

Connect on LinkedIn
http://www.elsevier.com